Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterized by the involvement of multiple organs. Lupus nephritis (LN) is a major risk factor for overall morbidity and mortality in SLE patients. Hence, designing effective drugs is pivotal for treating individuals w...
Main Authors: | Shogo Ijima, Yuki Saito, Kentaro Nagaoka, Sena Yamamoto, Tsukasa Sato, Norihiro Miura, Taiki Iwamoto, Maki Miyajima, Takako S. Chikenji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.960601/full |
Similar Items
-
Mannose-binding lectin gene polymorphism in systemic lupus erythematosus nephritis
by: Osama Sayed Daif Allah, et al.
Published: (2021-06-01) -
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
by: Michelle T. Barati, et al.
Published: (2022-02-01) -
Hemophagocytic lymphohistiocytosis secondary to virus infection and followed by lupus nephritis recurrence in a renal transplantation pediatric recipient: a case report
by: Jiyuan Li, et al.
Published: (2023-07-01) -
Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
by: Meriam Hajji, et al.
Published: (2023-06-01) -
Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)